News German pricing rules hit Eisai's Halaven Drug has "no additional benefit" in metastatic liposarcoma, says IQWiG.
News Eisai angry over thyroid cancer drug impasse in England Thyroid cancer drug falls through gap in NHS funding
News Patients denied thyroid cancer drug in England Eisai considers legal action over funding "black hole".
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
